According to a new research, Sanofi-Aventis's chemotherapy drug Jevtana, enhances survival chances by 30% in men suffering from prostate cancer, whose tumors do not react to normal treatment.

Although Sanofi had already said that Jevtana, or cabazitaxel, had achieved its target in the 755-patient test, analysts were waiting to look at the details.

French drugs company Sanofi-Aventis on Wednesday announced its plans to continue with acquisitions and concentrate on small- and midsize targets, as it witnessed a 10% rise in fourth-quarter net profit, triggered by sales of its key drugs, including Lantus and Lovenox, as well as an extra boost from vaccines.

Sanofi-Aventis SA announces its plans to continue with its acquisitions of as much as $15 billion as the French drug maker looks forward to replace revenue that it's losing to competition from generic medicines.

French drugmaker Sanofi-Aventis on Tuesday announced to have completed its tender offer for shares of Chattem Inc., which makes Gold Bond skin products, Icy Hot pain relief packs, and Selsun Blue dandruff shampoo.

On Wednesday U. S. health officials approved a high-dose influenza vaccine for people aged 65 years and more. The vaccination is made by Sanofi-Aventis DA (SASY. PA).

The Food and Drug Administration said that the immune system becomes stronger with a higher dose that protects aged people better against seasonal flu.

As has been confirmed by the pharmaceutical giant, Sanofi-Aventis is looking to purchase US consumer health group Chattem Inc. in a deal which will cost the former a whopping $1.9 Billion, and the purchase will give the French drug manufacturer over-the-counter presence across the US.

Sanofi-Aventis changed its outlook for 2009. This happened due to the sales of swine flu vaccine and earnings posted per share growth that beat forecasts. The competition from other generics was deferred by revenue growth for other drugs.

Chris Viehbacher, the CEO of Sanofi-Aventis SA informed during an interview that they will keep shopping for acquisitions to build vaccine, biotechnology and nonprescription medicine businesses.

A big sum of 6.2 billion euros has already been spent this year on acquiring health-care companies and products as part of a strategy to bolster "five growth platforms".

As per the findings of the double-blind phase II SEPIA-ACS1/ TIMI-42 study, Otamixaban - an experimental anti-clotting drug manufactured by the French pharmaceutical company Sanofi-Aventis - can better prevent cardiac complications as well as deaths in heart patients having suffered mild attacks and severe chest pain, vis-à-vis standard treatment.

The Food and Drug Administration gathered over 35 experts for a two day meeting to find ways to prevent acetaminophen overdose. Acetaminophen is the pain reliving and fever reducing ingredient that is found in drugs like Tylenol and many other prescription and over the counter medications.